JANX icon

Janux Therapeutics

49 hedge funds and large institutions have $388M invested in Janux Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$24.3M
2 +$5.71M
3 +$1.54M
4
Morgan Stanley
Morgan Stanley
New York
+$1.54M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.5M

Top Sellers

1 -$658K
2 -$609K
3 -$141K
4
N
Nuveen
North Carolina
-$27K
5
Goldman Sachs
Goldman Sachs
New York
-$24.6K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$190K
27
$181K
28
$180K
29
$165K
30
$144K
31
$110K
32
$110K
33
$103K
34
$92K
35
$38.4K
36
$30K
37
$24K
38
$18.7K
39
$16K
40
$13K
41
$13K
42
$10K
43
$5K
44
$3K
45
$2K
46
$2K
47
$1K
48
$1K
49
$1K